Wnt

MDGCEL is a WNT5A peptide that functions as an antagonist to WNT5A signaling. It mimics WNT5A, providing utility in research focused on modulating WNT signaling pathways. MDGCEL is valuable in studies investigating developmental biology, cell signaling, and cancer research, where the regulation of WNT5A activity is crucial.

Box5 is a potent antagonist of Wnt5a, specifically designed to inhibit Wnt5a signaling pathways. This compound effectively reduces Wnt5a-mediated calcium ion release and inhibits cell migration, making it a valuable tool in the study of cellular dynamics. Box5 has significant potential for research applications in melanoma, facilitating the exploration of therapeutic interventions targeting Wnt5a signaling.

Foxy-5 is a WNT5A agonist that functions as a mimetic peptide of the WNT5A protein, a key player in non-canonical Wnt signaling pathways. It induces cytosolic free calcium signaling while leaving β-catenin activation unaffected, and has been shown to inhibit the migration and invasion of epithelial cancer cells. Additionally, Foxy-5 effectively reduces metastatic spread in WNT5A-low prostate cancer cells within an orthotopic mouse model, making it a valuable reagent for cancer research and therapeutic investigations.

Wnt/β-catenin agonist 4 (Derivative 83) is a potent agonist of the Wnt signaling pathway that stimulates Wnt/β-catenin signal transmission. This compound plays a crucial role in enhancing cellular processes regulated by Wnt signaling, such as cell proliferation, differentiation, and tissue regeneration. It is useful in various research applications, including studies on developmental biology, cancer progression, and regenerative medicine.